Omramotide
Omramotide is an immunological agent for active immunization (antineoplastic) [1].
Product Specifications
CAS Number
2306406-71-1
UNSPSC
12352209
Target
Others
Type
Peptides
Related Pathways
Others
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/omramotide.html
Solubility
10 mM in DMSO
Smiles
N[C@@H](CC1=CC=CC=C1)C(N[C@@H](CC(C)C)C(N2[C@@H](CCC2)C(N[C@H](C(NCC(N[C@H](C(N[C@@H]([C@@H](C)CC)C(N[C@@H](CC(C)C)C(N3[C@@H](CCC3)C(N[C@H](C(O)=O)C(C)C)=O)=O)=O)=O)CC4=CC=CC=C4)=O)=O)CC5=CC=CC=C5)=O)=O)=O
Molecular Formula
C62H88N10O11
Molecular Weight
1149.42
References & Citations
[1]Chene, et al. Immunogenic compounds for treatment of adrenal cancer. World Intellectual Property Organization, WO2021074389 A1. 2021-04-22.
Shipping Conditions
Room temperature
Scientific Category
Peptides
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
039233-ML405 100 µL
NXNL2, ID (NXNL2, C9orf121, Nucleoredoxin-like protein 2) (MaxLight 405) discontinued
Sign In for Pricing
View Details 040391-AP 200 µL
PRAMEF6, CT (PRAMEF6, PRAME family member 6) (AP) discontinued
Sign In for Pricing
View Details 